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Abstract
Background The palatability of flucloxacillin oral liquid is poor. Parents/carers
use strategies to aid the administration of poorly palatable medicines.
Aim To assess views on the palatability of flucloxacillin oral liquid and identify
factors associated with successful administration.
Methods A mixed methods study which included a structured review of online
forums and a survey of parent/carers of children with cystic fibrosis (CF) to
obtain parent/carer views on the administration of flucloxacillin oral liquid.
Results A total of 18 strategies to aid the administration of flucloxacillin sus-
pension to children were identified on 10 different public online forums. A
total of 255 responses to the open online survey were received with 47% of
respondents reporting that administration of flucloxacillin was more problem-
atic compared to other medicines and 38% reporting the need to improve the
palatability.
The brand of flucloxacillin oral liquid significantly influenced the degree of dif-
ficulty associated with administration to children. A significant relationship was
found between the concentration of flucloxacillin and the reported number of
doses successfully administered. The use of food and drink to aid administra-
tion was more commonly stated in online forums (44%) compared to the sur-
vey data of parents/carers of children with CF (15.9%).
Conclusion The administration of flucloxacillin oral liquid is perceived as a
challenge by parent/carers because of palatability. For chronic use, a more con-
centrated oral liquid and certain brands are likely to improve acceptability.
Introduction
Poor palatability of paediatric medicines has the potential
to influence adherence to therapeutic regimens and out-
comes.[1–3]
Flucloxacillin was the second most commonly pre-
scribed penicillin (following amoxicillin) within the UK
in 2012.[4] The UK guidelines recommend that babies
with cystic fibrosis (CF), should be started on flu-
cloxacillin (125 mg twice daily) as antibiotic prophylaxis
to prevent airway infection with Staphylococcus aureus.[5]
The current recommendations suggest this should be until
the child is 3 years of age, although for most UK clinics
the antibiotic is continued beyond this age. A trial in
healthy child volunteers (conducted in the USA) reported
that cloxacillin (similar tasting to flucloxacillin) tasted sig-
nificantly worse than other antibiotics.[6] It is widely
reported among healthcare professionals that flucloxacillin
is poorly palatable with recommendations that the child
is observed swallowing a dose prior to full prescrip-
tion.[3,7] Specific issues with flucloxacillin administration
to children were identified by healthcare professionals in
© 2016 Royal Pharmaceutical Society International Journal of Pharmacy Practice 2016, , pp. –
International Journal of
Pharmacy Practice
Research Paper
International Journal of Pharmacy Practice 2016, , pp. –
the UK, with one nurse suggesting giving a sweet (candy)
after administration to improve acceptance.[8]
The extent to which dosage forms are manipulated to
improve taste is unknown. Health professionals previously
estimated that 10–30% of people modify their medicines.[9]
Mixing medicines with food is often undertaken in a paedi-
atric setting to improve palatability, typical foods used
within a hospital setting include jam, custard, yoghurt,
honey, juice and water.[10] Data from parents suggest that
up to 40% of medicines are mixed with food to improve
palatability.[11–13] Although mixing medicines into food/
drink is common practice by parents and within paediatric
wards,[14] there is no evidence base for this manipulation
and this is an area where further guidance is required.[15]
Flucloxacillin stability is pH dependent, with maximum
stability at pH 6.5; and more rapid degradation at lower pH
values.[16] Therefore, the pH of food mixed with flu-
cloxacillin may affect its stability prior to ingestion. Mixing
of flucloxacillin with food may impact on drug stability and
absorption, which may reduce efficacy. Sutherland et al.[17]
reported a delay in the absorption of flucloxacillin and 50%
overall reduction in the concentrations obtained following
dosing adults in the fed state compared to the fasting state.
Bergdahl et al.[18] conducted a study in children that com-
pared the absorption of flucloxacillin in the fed and fasted
state; the results did not show significant differences in the
overall exposure (of the drug as a result of food in those
aged 0.5–4 years, however, there appeared to be a signifi-
cant (P < 0.05) increase in the exposure in those aged 0–
1 months in the presence of food) as well as a delay in the
Tmax. The patient information leaflet for flucloxacillin states
that it should be taken half to one hour before food.[19–21]
A number of helpful websites have reported strategies
to support parent/carers with administration of medicine
to children (e.g.[22–24]). The information is not derived
from a clear evidence base and it is difficult to translate
this advice to specific populations or medicines.[25]
The aim of this study was to assess the extent to which
palatability of flucloxacillin oral liquid is a barrier to
administration and to compile resources to support par-
ents/carers and improve administration of flucloxacillin
oral liquid to children. The administration of medicine is
linked to acceptability and often easing administration
requires improving the acceptability of the medicine to
the child. This study links improving acceptability to ease
administration throughout.
Methods
Review of online forums
A systematic search of online forums was conducted using
the search terms ‘flucloxacillin’ AND ‘taste’ OR
‘palatability’ OR ‘child’ within a standard Google search
to identify reports of strategies used by parents/carers to
aid administration of flucloxacillin to children. Online
discussion forum websites were selected based on their
popularity and common usage (by looking at the number
of users (where data was available) and the frequency of
posts) by the UK population (rather than among special-
ist interest groups or social media superusers). This type
of analysis is classified as passive analysis with low intru-
siveness, that is, analysis of information patterns and
interactions on discussion groups of which researchers
have not been part. Information from these forums was
extracted using a template to capture the age of the child;
the reason for using flucloxacillin (acute versus chronic
use); the reason why flucloxacillin administration was an
issue; and the strategy employed by the parent/carer. The
acute (treatment for infections) versus chronic (prophy-
lactic treatment) use was assessed by the original post to
note the reason for prescribing flucloxacillin; where infor-
mation was missing this was recorded as not stated.
Survey of parents/carers of children with CF
Study design
A bespoke survey was developed based on key questions
that were identified by a multidisciplinary team (respira-
tory consultant; pharmacist; CF patient representative
(adult); parent of a child with CF and academic
researcher in paediatric medicines); relevant literature and
the review of online forums to collect information on
strategies that parents currently use or have used previ-
ously to aid in the administration of oral liquid flu-
cloxacillin to children with CF.
Participants and recruitment
For this survey, parent/carers of children with CF were
identified as the target population with inclusion criteria
being that the survey participant identifies as caring for a
child with CF who has taken oral liquid flucloxacillin (no
exclusion criteria). Potential participants were recruited
via distribution of the survey uniform resource identifier
(URL) via three-closed CF parent Facebook groups (total
of 4840 members) and two-open CF family Facebook
groups (total of 1092 members). It was also shared on
Twitter by the Cystic Fibrosis Trust (19 000 followers)
and CF Aware (10 000 followers).
Survey development
The survey was constructed with fixed options as well as
free text comments on questions to allow the best quality
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data to be generated while minimising the time burden to
participants. Key areas of interest included: strategies used
to administer oral liquid flucloxacillin based on the age of
the child ranging from a pre-weaned child to an adoles-
cent; the formulation of oral liquid flucloxacillin used (in-
cluding brand and strength); the extent of the issue of
administration of oral liquid flucloxacillin (compared to
other medicines); the use of (1) food/drink, (2) devices
and (3) encouragement to aid in the administration of
oral liquid flucloxacillin (with a request to include exam-
ples). A draft questionnaire was reviewed by the multidis-
ciplinary team to assess ease of completion and ensure
that questions were phrased unambiguously. The online
survey software, Bristol Online Survey, (www.onlinesur
veys.ac.uk) was deemed most appropriate as it is specifi-
cally designed for academic research and public sector
organisations and is fully compliant with the UK data
protection laws. A non-probability-based convenience
sampling method was selected and individuals were left
with a choice to ‘opt in’ to the questionnaire following an
invitation. A target sample size was not set as this was a
consultation and not research therefore statistical power-
ing is not relevant. However, it was felt that at least 200
responses were required to ensure that the results were
representative. The survey used in this study was
approved by the University of Birmingham Science, Tech-
nology, Engineering and Mathematics (STEM) Ethical
Review Committee (reference ERN_14-1257). The ques-
tionnaire was launched on 3rd February 2015 with an end
date of 3rd March 2015. The final survey is included as
Table S1.
Data coding and analysis
For closed-ended questions, questionnaire data was trans-
lated into numerical code on IBM SPSS statistical soft-
ware package (IBM SPSS Statistics for Windows, Version
22.0., Armonk, NY, USA) to allow the results to be anal-
ysed in order to assess the significance of patterns and
relationships in the data (P < 0.05 was the cut off for sta-
tistical significance). Cross-tabulations and 2 9 2 tables
were used to compare the relationship between questions,
with non-parametric chi-squared tests being used to anal-
yse the significance of relationships between two ques-
tions/variables; further, Cramer’s V coefficient was
calculated to assess the strength of the association
between the two variables.
Results
Passive analysis of online forums
A total of 18 unique reports on the administration of flu-
cloxacillin oral liquid were identified on 10 different pub-
lic online forums (Table 1). Details of the online forums
included are listed in Box 1. Eight responses recom-
mended mixing flucloxacillin with food/drink. Milk was
commonly used for children aged 6–20 months; honey,
Table 1 Reports identified on public online forums to aid the administration of flucloxacillin to children
Patient characteristics Strategy reported
Age of child (months) Treatment duration Mixed with food/drink Device used Reward Other methods
6 Chronic Milk
6 Not stated Syringe Sing songs
8 Acute Dip syringe in Calpol (Johnson &
Johnson Ltd, Berkshire, UK)
15 Not stated Syringe Pretend to give to pet
15 Acute Syringe Fruit pastille
20 Acute Formula milk
20 Acute Syringe
21 Acute Honey
22 Acute Syringe
24 Acute Magic stars
24 Acute Yoghurt, Nutella Syringe
24 Acute Yoghurt
36 Acute Jam, yoghurt, honey,
fruit-flavoured drink,
Vimto
Syringe
36 Acute Calpol, milk, sugar
36 Acute Ice cream Syringe
36 Acute Fruit-flavoured drink Chocolate fudge
84 Acute Drink of water after
120 Acute Sweets/fizzy drink
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Nutella (Ferrero Group, Turin, Italy), jam, ice cream
and fruit-flavoured drinks for those aged 21–36 months.
The use of an oral syringe to direct the medicine slowly
into the back/side of the mouth was also reported as a
method to ease administration compared to the medicine
spoon supplied with the product. The use of rewards fol-
lowing administration of flucloxacillin was reported, with
most being food-based.
The unpleasant taste of flucloxacillin was described in
several forums, examples of such statements include:
It’s absolutely rancid and I don’t know why they
offer it to young children. (Netmums contributor)
Floxapen brand of flucloxacillin actually tastes quite
nice, it’s the other unbranded stuff that’s vile for
some reason. (Damsels: the women’s network con-
tributor)
Survey responses from parents/carers of
children with CF
A total of 255 responses to the questionnaire were
received, eight responses (3%) were received from outside
of the UK. Only two respondents reported that their child
had never previously taken and was not currently taking
flucloxacillin oral liquid; their answers were removed
from the analysis.
Fourty-seven percent of parents/carers reported the
administration of flucloxacillin was more problematic than
other medicines. Of those who answered ‘more’ (n = 119),
the majority (73.1%) of parents/carers reported that it was
the taste of flucloxacillin which made it more difficult to
administer. In addition, 30.2% of parents/carers answering
‘more’ stated that their child would spit out the medicine,
retch or vomit. Administration was the greatest issue in
pre-weaned children as shown in Table 2.
llustrative quotes from parents regarding the impact of
age on administration of flucloxacillin liquid are provided
below, these quotes suggest that as the child gets older
administration becomes less of an issue for children with
CF.
Initially it was very, very difficult, however, my
daughter eventually got used to it. (Participant 91)
Initially when our daughter was a tiny baby, it was
by far the most difficult to give. She is now 3 and
actually likes it though! (Participant 12)
The taste was unbearable. I think he managed the
sugar-free version in the end and I suppose after a
year of administration he got used to the taste.
(Participant 196)
The chi-squared analysis revealed a strong relation-
ship between the responses to the question ‘To what
extent do you agree with the statement “I find/found
the administration of flucloxacillin problematic”?’ and
‘How many of the recommended doses of flucloxacillin
do you/did you manage to successfully administer?’
(v2 = 78.5; P < 0.001; Cramer’s V = 0.40). The major-
ity (89.3%) of parent/carers reported that they admi-
nister/administered ‘most doses’ or ‘all doses’ of
flucloxacillin.
There were 36 reports that a child spat out the medi-
cine, retched or vomited which suggest over reporting of
achieving most or all doses. The questionnaire did not
define administration as swallowing the complete dose;
therefore, some parents may interpret administering all
doses as providing them to the child yet not ensuring that
the child swallowed the medicine.
Fourty-nine percent of respondents were unaware of
the flucloxacillin brand that they administered to their
child. A significant relationship was found between the
brand of flucloxacillin administered and whether parents/
carers agreed or disagreed with the statement ‘I find/
Table 2 Impact of child’s age on the parents/carers response to
‘Compared to other medicines you have had to administer to your
child, do you/did you find the administration of flucloxacillin more or
less problematic?’
n
How problematic compared to
other drugs (% of parents/carers)
More Less No different
Pre-weaning 21 90.4 4.8 4.8
Post-weaning - 2 years 80 42.4 11.3 46.3
3–5 years 68 50.0 13.2 36.8
6–11 years 61 36.1 4.9 59.0
12–17 years 23 43.5 17.4 39.1
Box 1 Online forums included.
• Mumsnet (www.mumsnet.com).
• Netdoctor (www.netdoctor.co.uk).
• Netmums (www.netmums.com).
• Bub Hub (www.bubhub.com).
• Cystic Fibrosis Trust Forum (http://forum.cysticfi-
brosis.org.uk/).
• Treasures (www.treasures.co.nz).
• HealthUnlocked (www.healthunlocked.com).
• BabyCentre (www.babycentre.co.uk).
• Yahoo Answers (https://uk.answers.yahoo.com/).
• Damsels: the women’s network (www.damsels.org).
• Frightful Bish (https://frightfulbish.wordpress.com/).
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found the administration of flucloxacillin problematic’
(v2 = 11.2; P = 0.047). Cramer’s V analysis implied a
moderate association (V = 0.21) where parents/carers
administering Crescent Pharma and Medreich brands
were least likely to agree that flucloxacillin administration
is problematic (data shown in Figure 1). Some parents
referred to Floxapen brand of flucloxacillin which was
withdrawn in 2009.[26] A full list of brands available
together with the flavouring agents used in each product
is included in as Table S2.
A significant relationship was found between the con-
centration of oral liquid and the number of doses success-
fully administered (v2 = 10.3; P = 0.035). Only 6% of
parents administering the stronger strength product
(250 mg/5 ml) reported administering ‘no’ or ‘some
doses’ in comparison with 12% of parent/carers adminis-
tering 125 mg/5 ml. The increase in acceptability of the
more concentrated flucloxacillin product may be corre-
lated with the increased age of the child as older children
are more likely to be prescribed the stronger product,
however, our data did not allow this analysis due to the
sample size.
Example quotes from parents are included to highlight
these findings related to specific products.
Had the same brand for a while..child took it no
bother..now it’s this new one he’s not too keen!!
(Participant 144)
It was the most problematic when she was on the
lower strength, so therefore more {volume} and
sugar-free. She now takes the 250 mg/5 ml normal
(not sugar free) fine. (Participant 182)
Giving less with stronger strength and sticking with
the sugar variety helped. (Participant 201)
My daughter is now on capsules she is 6 but taken
capsules since aged 3. (Participant 34)
Our hospital started my son on capsules before the
age of 4 which has made things much easier. (Par-
ticipant 77)
Sixteen percent of parent/carers reported that mixing
with food/drink eased the administration of flucloxacillin.
However, a further 13% reported that mixing with food
or drink did not help with administration. Furthermore,
it was reported by 4% of parents/carers who had mixed
with food/drink that the child would actually refuse to
then consume the food or drink in the future. The chi-
squared analysis found a significant relationship between
mixing with food/drink and whether the parents/carer
found flucloxacillin administration problematic
(v2 = 22.7; P < 0.001), with a strong relationship between
the two (Cramer’s V = 0.30). Based on the odds ratio,
those who mixed with food/drink were 3.1 times more
likely to describe administration as problematic. The dif-
ferent foods/drinks that were recommended changed with
age where milk was used in pre-weaned babies and also
being recommended for children up to 5 years old. In
children aged 3–11, mixing with juice was popular, with
hot chocolate also being described. Yoghurt was men-
tioned for all age groups that were weaned. Illustrative
quotes from parents/carers regarding the co-administra-
tion of flucloxacillin liquid with food or drink highlight
common issues identified.
I tried to give with food, and even mix into drink,
but it didn’t help. (Participant 43)
I give it while she’s drinking her bottle as she sucks
and takes it without realising but she’s getting bet-
ter at taking it straight from a syringe if in a good
mood. (Participant 101)
We tried to mix with yoghurt. He now won’t eat
yoghurt because he thinks it tastes like that. (Partic-
ipant 121)
We were told by our nurse that it should not be
added to milk or given with milk as that affected
its potency. So we didn’t do it. (Participant 136)
Fifty-one percent of parent/carers provided current/for-
mer strategies used to aid the administration of flu-
cloxacillin oral liquid in pre-weaned babies. The most
common strategy for pre-weaned babies was to use an
oral syringe (and not the medicine spoon supplied) where
flucloxacillin is administered slowly into the side or cor-
ner of the mouth. The use of a medicine dummy (soother
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Figure 1 The percentage of parents/carers for each brand of flu-
cloxacillin administered reporting ‘agree’ or ‘strongly agree’ in answer
to the question, ‘To what extent do you agree with the statement ‘I
find/found the administration of flucloxacillin problematic’?.
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medicine dispenser) and bottle teat were also described as
strategies for the younger age groups. About 15.8% of
parents/carers found that encouragement was helpful in
the administration of flucloxacillin as children were older.
The most commonly reported ways to encourage children
to take flucloxacillin were praise (16.3% of parents/car-
ers), sweets (16.3% of parents/carers) and stickers (12.7%
of parents/carers).
All survey participants were invited to provide any
comments on how the administration of flucloxacillin
could be improved, and out of 254 participants, 162
(64%) participants chose to respond. Table 3 shows com-
mon themes.
There were many negative comments made within this
section, illustrated by,
..it’s very traumatic for a parent with a newly diag-
nosed (CF) child to have to deal with trying to
force this (flucloxacillin) down their throat. (Partic-
ipant 15)
Over one-third (38.3%) of parents/carers in this study
reported that they thought administration of flucloxacillin
could be eased by a more pleasant taste or flavour. About
11.1% parents/carers of children with CF recommended
moving from the flucloxacillin oral liquid to capsules to
avoid the issue with taste and seven parents/carers
reported children starting taking flucloxacillin capsules
between 18 months and 4 years of age.
Discussion
Main Findings
This study supports previous reports of the poor palata-
bility of flucloxacillin oral liquid with several unprompted
Internet-based reports of difficulties in administration to
children and 34% of parent/carers of children with CF
reporting that taste makes administration of flucloxacillin
more problematic than other medicines. Online forum
data revealed that administration issues were most com-
mon in children 3 years or younger; this was supported
by findings from the survey of parents/carers of children
with CF who identified that the issues around administra-
tion are greatest in the youngest children. The most prob-
lematic age group for the administration of flucloxacillin
oral liquid was reported to be pre-weaned babies; there-
fore, strategies to aid administration in this age group are
likely to be particularly beneficial.
Strengths and limitations
This is the first study to collect data on parent/carer strate-
gies on the delivery of flucloxacillin oral liquid to children.
Online forums are useful sources of information regarding
medicines administration although the authors recognise
that only serious issues are likely to be raised and this may
introduce some bias into the results. However, in identifica-
tion of parent strategies in administration of flucloxacillin,
it is the responses to the originator post that are of most
interest. The use of a survey to parents/carers of children
with CF provided a means to gather data from a population
known to be experienced in the administration of flu-
cloxacillin oral liquid to children; however, it is acknowl-
edged that the survey used free text responses to explore the
reasons why administration was problematic rather than
quantifying all possible reasons. This approach was selected
to minimise bias and allow parents/carers to provide infor-
mation on all aspects of administration rather than being
prompted by the use of potentially leading questions.
It is acknowledged that parents/carers experiencing an
issue with the administration of flucloxacillin are more
likely to respond to a survey; however, as the results will
be used to develop a support package for parents/carers
that do experience an administration issue, this popula-
tion selection is appropriate.
The use of an online survey provides wide reach into
the CF population as it can be distributed easily and par-
ents/carers have the option to opt in without pressure,
however, it will only reach those parents/carers who are
active in a CF social media network which was a recog-
nised limitation of the study. This approach to distribu-
tion of the survey was selected as a link or message from
an existing contact is typically less likely to be deleted or
ignored. The distribution was centred around the UK CF
population although the Facebook groups and Twitter
accounts are open to other parents/carers/patients with
CF globally; however, they are likely only to be accessed
in English-speaking countries. Although this was a quali-
tative study with non-probability sampling techniques
where the sample size is not critical, an estimate of the
number of children with CF in the UK is 4500 (Clinical
guidelines: care of children with cystic fibrosis 2014);
therefore, the participants represent ~5% of the total pop-
ulation within the UK.
Table 3 Themed strategies reported to improve administration of
flucloxacillin oral liquid (n = 162 in total; n > 5 was required for a
topic to be considered a theme)
Strategy Frequency
Improve the taste/flavour of the product 62
A positive parent/carer attitude 18
Identify a favourite brand 13
Use a sugar-containing brand 9
Move onto the capsule product as
soon as the child is able to swallow this product
18
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What is already known on this topic
Previous reports of adherence to oral antibiotics are ~50%
for four times daily dosing (as with flucloxacillin prescribed
for acute infections) and ~70% for twice daily administration
as in CF patients.[27] However, there is evidence that parents
over report compliance to medication (e.g.[28,29]). This study
found that almost 90% of parents/carers reported adminis-
tering all or most of the doses of oral liquid flucloxacillin to
their child which is higher than previous reports.
It is already known that nurses use food/drink to mix with
medicines within a ward setting[14] and there are previous
reports of parents mixing medicines with food and drink
with values of up to 40% of medicines being mixed with
food/drink.[12,13] The online forums primarily reported
strategies used to aid administration of flucloxacillin oral
liquid to children with an acute illness and the use of food as
a co-administration aid to improve palatability was more
common that reports from parents/carers of children with
CF (a chronic illness). Although mixing medicines into
food/drink is common practice, there is no evidence base for
this manipulation and that this is an area where further
guidance would be beneficial as messages to parents/carers
are often confusing and there is no evidence base to support
co-administration of flucloxacillin with food.[15] The lower
incidence of using food as a co-administration aid in chil-
dren with CF may be attributed to the comparative medici-
nes related knowledge base of parents with a chronically ill
child compared to those with a child with an acute illness.
Further research is needed to evaluate the consequences of
co-administration of flucloxacillin with food.[15]
Taste is one of the most common barriers to administra-
tion of medicines to children.[3] This may be why the
administration of flucloxacillin becomes easier with age, as
the child can swallow a capsule which removes the issue of
taste. The age at which children convert to capsules was not
recorded in this study. The summary of product characteris-
tics for flucloxacillin capsules does not have an age where
these are considered appropriate, however, the minimum
dose of 250 mg suggests that this would only be appropriate
for the treatment of certain children as, for example, the
dose banding does not permit treatment for primary pre-
vention of Staphylococcus aureus lung infection in cystic
fibrosis (125 mg twice daily).
Implications for practice and
recommendations
Information gathered from parents and carers on strate-
gies to aid the administration of oral liquid flucloxacillin
to children can be used to advise other parents/carers on
the administration of flucloxacillin and other poorly
palatable medicines to children.
The parent/carer recommendations within this study
include:
 The use of an oral syringe was commonly reported to
improve issues around administration within the online
forums; this is a standard medical device and is com-
monly used in the administration of liquid medicines to
children; however, the ability to direct the medicine
more accurately than using a spoon seems to be of ben-
efit to children. Typically, flucloxacillin is supplied with
a spoon and not an oral syringe.
 Using a higher strength product reduces the volume to
be administered and this appears to have a beneficial
impact on administration.
 Certain brands were also highlighted as having fewer
issues (Medreich and Crescent); however, it is not clear
why these brands are preferred. The flavours used in the
more popular brands are pineapple and menthol in
Medreich, and cherry in Crescent; Actavis brand which
was the least popular uses menthol, lemon and straw-
berry as flavouring agents and Milpharm another less
popular brand uses pineapple and menthol (as Medre-
ich) (full details of all formulations are included in
Table S2).
 Parents faced with long-term administration should seek
advice from their pharmacy with respect to identifying
a preferred flucloxacillin brand and maintaining that
supply.
 Co-administration with food was reported to improve
administration when flucloxacillin was indicated for the
treatment of acute illnesses. However, it is not possible
to provide any advice on foods that were more or less
successful as the survey was not designed to answer this
question.
Conclusion
The administration of flucloxacillin oral liquid to children
can be a challenge and parent/carers should be supported
with this task. Previous knowledge of the impact of food
on the bioavailability of flucloxacillin in children is not
conclusive.[18] Regular reports of mixing flucloxacillin
with food highlights the need for additional research to
understand the impact on pharmacokinetics of co-admin-
istration with food to improve palatability rather than
dosing with a full meal. These data demonstrate the need
for production of more palatable paediatric formulations
of flucloxacillin. It is important that manufacturers and
regulators aid the development of more palatable medici-
nes for children where possible.
These data will facilitate the production of resources to
support parents/carers in the administration of flu-
cloxacillin (and other unpalatable medicines) highlighting
the importance of a positive attitude, persistence and
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specific strategies relating to the product brand and con-
centration. These resources may have important implica-
tions for the delivery of future clinical trials and to
improve adherence to poorly palatable medicines used in
paediatric practice.
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